Trial intelligence / Profile preview

Fruquintinib in Patients With Metastatic Colorectal Cancer Refractory to Standard Chemotherapies in South Korea (FIRST-K)

KCT0012353Phase 2Not yet recruiting

Sponsor

Takeda

Start

Aug 2026

Modality

Orthosteric Ligands → Classical Binding Small Molecules → Small Molecules, Allosteric Modulators → Classical Binding Small Molecules → Small Molecules, Irreversible Covalent Inhibitors → Covalent Small Molecules → Small Molecules

Countries

1